NEW YORK (GenomeWeb News) – Pacific Biosciences today announced an agreement with Roche Diagnostics to develop diagnostic products based on PacBio's SMRT technology.
Including upfront, milestone, and supply payments, the deal is potentially worth more than $75 million to PacBio.
NEW YORK (GenomeWeb News) – Illumina said today that it will partner with Global Genomics Group (G3) to provide whole-genome sequencing for the Genetic Loci and the Burden of Atherosclerotic Lesions, or GLOBAL, clinical trial.
NEW YORK (GenomeWeb News) – Privately held Chinese diagnostics services firm iGenomics has purchased 17 of Life Technologies' Ion Proton next-generation sequencing systems and has agreed to add 15 more machines by the end of the year, Life Tech said today.
NEW YORK (GenomeWeb News) – A team of clinical researchers in Vancouver has received C$5 million (US$4.8 million) in new funding to use next-generation sequencing to improve methods for testing for drug resistance in HIV/AIDS patients, Genome British Columbia said today.
NEW YORK (GenomeWeb News) – French biomarker firm Skuldtech today announced it has been awarded €1 million ($1.3 million) in funding to support work on developing diagnostic tests for an Alzheimer's drug in development.
NEW YORK (GenomeWeb News) — Four research teams across the US have been awarded a total of $5 million in fiscal year 2013 under a new Genomic Sequencing and Newborn Screening Disorders program jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development an
NEW YORK (GenomeWeb News) – Illumina said today that it has entered into a three-year supply agreement with Natera, under which Natera will run its noninvasive prenatal test Panorama on Illumina's HiSeq 2500 and use the associated Illumina consumables.